공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 전임상 CRO 시장(2021-2027년) : 시장 예측(서비스, 최종 용도, 지역별), 업계 동향, 지역 전망, 응용 잠재성, 가격 동향, 시장 점유율

Preclinical CRO Market Size By Service, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 02월 상품 코드 987838
페이지 정보 영문 104 Pages
가격
US $ 5,150 ₩ 5,821,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,081,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 10,342,000 Printable PDF (Enterprise User License)


세계의 전임상 CRO 시장(2021-2027년) : 시장 예측(서비스, 최종 용도, 지역별), 업계 동향, 지역 전망, 응용 잠재성, 가격 동향, 시장 점유율 Preclinical CRO Market Size By Service, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 02월 페이지 정보 : 영문 104 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

전임상 CRO 시장은 인공지능(AI) 등 새로운 첨단 기술의 적극적인 채택에 의해 향후 몇 년간 급성장을 나타낼 것으로 예측됩니다. 바이오의약품 기업, 의료기기 기업, 정부기관/학술기관의 수요 증가가 시장의 새로운 성장을 가속화할 전망입니다. 서비스별로는 bioanalysis & DMPK(약물대사 및 약동력학) 연구 부문이 2020년 20억 달러 이상 규모에 달했고, 향후 몇 년간 견실한 성장을 나타낼 것으로 예측됩니다.

세계의 전임상 CRO(Preclinical CRO) 시장을 조사했으며, 시장의 정의와 개요, 산업의 에코시스템, 코로나(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추이와 예측, 서비스·최종사용자·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 산업 인사이트

  • 산업 분류
  • 산업 상황
  • 산업 영향요인
    • 성장요인
    • 잠재적 위험&과제
  • 성장 가능성
  • Porter의 산업 분석
  • 경쟁 구도
  • PESTEL 분석

제4장 시장 분석과 예측 : 서비스별

  • bioanalysis & DMPK(약물대사 및 약동력학) 연구
  • 독성시험
  • 기타

제5장 시장 분석과 예측 : 최종사용자별

  • 바이오의약품 기업
  • 정부기관/학술기관
  • 의료기기 기업
  • 기타

제6장 시장 분석과 예측 : 지역/주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제7장 기업 개요

  • 경쟁 대시보드
  • Envigo Corporation
  • MPI Research
  • Eurofins Scientific
  • PRA Health Sciences
  • Wuxi App Tec
  • Medpace
  • Pharmaceutical Product Development
  • Parexel International Corporation
  • ICON
  • Laboratory Corporation of America
LSH 21.02.18

Data Tables

  • TABLE 1 Global preclinical CRO market, 2016 - 2020 (USD Million)
  • TABLE 2 Global preclinical CRO market, 2021 - 2027 (USD Million)
  • TABLE 3 Global preclinical CRO market, by service, 2016 - 2020 (USD Million)
  • TABLE 4 Global preclinical CRO market, by service, 2021 - 2027 (USD Million)
  • TABLE 5 Global preclinical CRO market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 6 Global preclinical CRO market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 7 Global preclinical CRO market, by region, 2016 - 2020 (USD Million)
  • TABLE 8 Global preclinical CRO market, by region, 2021 - 2027 (USD Million)
  • TABLE 9 Industry impact forces
  • TABLE 10 Bioanalysis & DMPK studies market size, by region, 2016 - 2020 (USD Million)
  • TABLE 11 Bioanalysis & DMPK studies market size, by region, 2021 - 2027 (USD Million)
  • TABLE 12 Toxicology testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13 Toxicology testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 14 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 16 Biopharmaceutical companies market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17 Biopharmaceutical companies market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18 Government & academic institutes market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19 Government & academic institutes market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20 Medical device companies market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21 Medical device companies market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24 North America preclinical CRO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 25 North America preclinical CRO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 26 North America preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 27 North America preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 28 North America preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 29 North America preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 30 U.S. preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 31 U.S. preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 32 U.S. preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 33 U.S. preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 34 Canada preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 35 Canada preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 36 Canada preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 37 Canada preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 38 Europe preclinical CRO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 39 Europe preclinical CRO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 40 Europe preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 41 Europe preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 42 Europe preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 43 Europe preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 44 Germany preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 45 Germany preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 46 Germany preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 47 Germany preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 48 UK preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 49 UK preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 50 UK preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 51 UK preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 52 France preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 53 France preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 54 France preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 55 France preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 56 Italy preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 57 Italy preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 58 Italy preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 59 Italy preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 60 Spain preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 61 Spain preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 62 Spain preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 63 Spain preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 64 Asia Pacific preclinical CRO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 65 Asia Pacific preclinical CRO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 66 Asia Pacific preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 67 Asia Pacific preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 68 Asia Pacific preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 69 Asia Pacific preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 70 Japan preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 71 Japan preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 72 Japan preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 73 Japan preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 74 China preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 75 China preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 76 China preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 77 China preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 78 India preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 79 India preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 80 India preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 81 India preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 82 Australia preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 83 Australia preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 84 Australia preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 85 Australia preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 86 Latin America preclinical CRO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 87 Latin America preclinical CRO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 88 Latin America preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 89 Latin America preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 90 Latin America preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 91 Latin America preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 92 Brazil preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 93 Brazil preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 94 Brazil preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 95 Brazil preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 96 Mexico preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 97 Mexico preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 98 Mexico preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 99 Mexico preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 100 MEA preclinical CRO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 101 MEA preclinical CRO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 102 MEA preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 103 MEA preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 104 MEA preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 105 MEA preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 106 South Africa preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 107 South Africa preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 108 South Africa preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 109 South Africa preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 110 Saudi Arabia preclinical CRO market size, by service, 2016 - 2020 (USD Million)
  • TABLE 111 Saudi Arabia preclinical CRO market size, by service, 2021 - 2027 (USD Million)
  • TABLE 112 Saudi Arabia preclinical CRO market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 113 Saudi Arabia preclinical CRO market size, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Break down of primary participants
  • FIG. 3 Preclinical CRO industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global preclinical CRO market, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by service
  • FIG. 7 Growth potential analysis, by end-use
  • FIG. 8 Porter's analysis
  • FIG. 9 Company matrix analysis
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by service
  • FIG. 12 Key segment trends, by end-use
  • FIG. 13 Key regional trends
  • FIG. 14 Competitive dashboard

Title:
Preclinical CRO Market Size By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.

The preclinical CRO market is poised to witness a lucrative rate of growth over the coming timespan due to robust adoption of new and advanced technologies such as AI. Increasing demand for enhanced preclinical CROs by biopharmaceutical companies, medical device companies, and government & academic institutes will further strengthen the business potential.

Preclinical CRO, also known as, pre-clinical Contract Research Organization, are firms that provide skills, knowledge, as well as experience required to convert a pharmaceutical or medical idea or concept into a final product.

The preclinical research services include numerous studies before the product is shown, including the stage of discovery and development, pre-clinical research stage as well as the clinical research stage and finally the review from FDA. In fact, the time period between pre-clinical tryouts and the launch of the product is where the preclinical CRO plays an important role.

The ideas related to drug and potential products might fail during this period, thus new and advanced preclinical CROs continue to look much deeper into the capacity of upcoming technology to surge efficiency in health research.

Nowadays, key Contract Research Organizations are starting to employ Artificial Intelligence in pre-clinical tests, thereby transforming the role of technology in healthcare. Clinical researchers are making use of reports generated by Artificial Intelligence to obtain actionable insights in their preclinical studies.

The preclinical CRO market is segmented in terms of service, end-use, and regional landscape.

With respect to service, the preclinical CRO market is classified into toxicology testing, bioanalysis & DMPK studies, and others. In 2020, bioanalysis & DMPK studies segment accounted for more than $2.0 billion and is anticipated to follow robust growth trend over the coming years. Bioanalysis is an important tool in drug discovery and development to determine the drugs concentration as well as their metabolites and numerous pharmacodynamics biomarkers in biological fluids.

DMPK or drug metabolism and pharmacokinetics studies are implemented all throughout the drug discovery, preclinical development, as well as clinical trials. These studies in animals are crucial for drug development as the gained data informs regarding the compound behavior in the humans.

In terms of application, the overall preclinical CRO market is bifurcated into government & academic institutes, medical device companies, biopharmaceutical companies, and others. Among these, the biopharmaceutical companies segment is expected to show a market revenue of more than $4.3 billion by the end of the analysis timeframe.

From a regional frame of reference, in 2020, preclinical CRO market in Latin America accounted for a market share of more than 4.5% and is slated to follow a strong growth trend over the coming time period.

Meanwhile, Middle East & Africa region will show a steady growth of 6.6% over the analysis time period.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Base estimates
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Preclinical CRO industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Service trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Preclinical CRO Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing R&D expenditure worldwide
      • 3.3.1.2 Growing outsourcing of R&D activities
      • 3.3.1.3 Rising number of drugs in preclinical trails
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Stringent regulatory policies
  • 3.4 Growth potential analysis
    • 3.4.1 By service
    • 3.4.2 By end-use
  • 3.5 Porter's analysis
  • 3.6 Competitive landscape
    • 3.6.1 Company matrix analysis
  • 3.7 PESTEL analysis

Chapter 4 Preclinical CRO Market, By Service

  • 4.1 Key segment trends
  • 4.2 Bioanalysis & DMPK studies
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Toxicology testing
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Others
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Preclinical CRO Market, By End-use

  • 5.1 Key segment trends
  • 5.2 Biopharmaceutical companies
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Government and academic institutes
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Medical devices companies
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Preclinical CRO Devices Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.2.2 Market size, by service, 2016 - 2027 (USD Million)
    • 6.2.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.2.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.2.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.3.2 Market size, by service, 2016 - 2027 (USD Million)
    • 6.3.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.3.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.3.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.3.6.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.3.7.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.8 Italy
      • 6.3.8.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.3.8.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.4.2 Market size, by service, 2016 - 2027 (USD Million)
    • 6.4.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.4.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.5 China
      • 6.4.5.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.4.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.4.6.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.4.7.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.5.2 Market size, by service, 2016 - 2027 (USD Million)
    • 6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.5.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.5.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.6 MEA
    • 6.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.6.2 Market size, by service, 2016 - 2027 (USD Million)
    • 6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.6.4 South Africa
      • 6.6.4.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.6.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size, by service, 2016 - 2027 (USD Million)
      • 6.6.5.2 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard
  • 7.2 Envigo Corporation
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Service landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 MPI Research
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Service landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Eurofins Scientific
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Service landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 PRA Health Sciences
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Service landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Wuxi App Tec
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Service landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Medpace
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Service landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Pharmaceutical Product Development
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Service landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Parexel International Corporation
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Service landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 ICON
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Service landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Laboratory Corporation of America
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Service landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
Back to Top
전화 문의
F A Q